title: Bevacizumab and cancer treatment-related mortality.
authors.forename: Cornelis J A
authors.initials: CJ
authors.lastname: Punt
authors.forename: Linda
authors.initials: L
authors.lastname: Mol
authors.forename: Miriam
authors.initials: M
authors.lastname: Koopman
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D015201:Meta-Analysis as Topic; D009026:Mortality; D009369:Neoplasms / Q000188:drug therapy*; D005791:Patient Care / Q000592:standards; D016032:Randomized Controlled Trials as Topic
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab